Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Knowledge of and beliefs about palliative care in a nationally-representative U.S. sample.

Taber JM, Ellis EM, Reblin M, Ellington L, Ferrer RA.

PLoS One. 2019 Aug 15;14(8):e0219074. doi: 10.1371/journal.pone.0219074. eCollection 2019.

2.

CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.

Stump TK, Aspinwall LG, Drummond DM, Taber JM, Kohlmann W, Champine M, Cassidy PB, Petrie T, Liley B, Leachman SA.

Genet Med. 2020 Jan;22(1):26-34. doi: 10.1038/s41436-019-0608-9. Epub 2019 Aug 2.

PMID:
31371819
3.

Implicit theories of smoking and association with interest in quitting among current smokers.

Thai CL, Rice EL, Taber JM, Kaufman AR, Klein WMP.

J Behav Med. 2019 May 20. doi: 10.1007/s10865-019-00058-9. [Epub ahead of print]

PMID:
31111356
4.

Adapting a self-affirmation intervention for use in a mobile application for smokers.

Taber JM, McQueen A, Simonovic N, Waters EA.

J Behav Med. 2019 Dec;42(6):1050-1061. doi: 10.1007/s10865-019-00028-1. Epub 2019 Mar 22.

PMID:
30903442
5.

Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.

Turbitt E, Roberts MC, Taber JM, Waters EA, McNeel TS, Biesecker BB, Klein WMP.

Prev Med. 2019 Jun;123:12-19. doi: 10.1016/j.ypmed.2019.02.027. Epub 2019 Feb 25.

PMID:
30817954
6.

"Keep it Realistic": Reactions to and Recommendations for Physical Activity Promotion Messages From Focus Groups of Women.

Thai CL, Taber JM, Oh A, Segar M, Blake K, Patrick H.

Am J Health Promot. 2019 Jul;33(6):903-911. doi: 10.1177/0890117119826870. Epub 2019 Jan 31.

PMID:
30704265
7.

Associations of perceived norms with intentions to learn genomic sequencing results: Roles for attitudes and ambivalence.

Reid AE, Taber JM, Ferrer RA, Biesecker BB, Lewis KL, Biesecker LG, Klein WMP.

Health Psychol. 2018 Jun;37(6):553-561. doi: 10.1037/hea0000579. Epub 2018 May 10.

8.

Intentions to share exome sequencing results with family members: exploring spousal beliefs and attitudes.

Turbitt E, Roberts MC, Ferrer RA, Taber JM, Lewis KL, Biesecker LG, Biesecker BB, Klein WM.

Eur J Hum Genet. 2018 May;26(5):735-739. doi: 10.1038/s41431-018-0118-2. Epub 2018 Feb 23.

9.

Skin cancer interventions across the cancer control continuum: A review of experimental evidence (1/1/2000-6/30/2015) and future research directions.

Geller AC, Dickerman BA, Taber JM, Dwyer LA, Hartman AM, Perna FM.

Prev Med. 2018 Jun;111:442-450. doi: 10.1016/j.ypmed.2018.01.018. Epub 2018 Feb 6. Review.

10.

Relationship of "don't know" responses to cancer knowledge and belief questions with colorectal cancer screening behavior.

Ellis EM, Ferrer RA, Taber JM, Klein WMP.

Health Psychol. 2018 Apr;37(4):394-398. doi: 10.1037/hea0000587. Epub 2018 Feb 1.

PMID:
29389156
11.

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Aspinwall LG, Stump TK, Taber JM, Drummond DM, Kohlmann W, Champine M, Leachman SA.

Transl Behav Med. 2018 Jan 29;8(1):29-43. doi: 10.1093/tbm/ibx011.

12.

Skin cancer interventions across the cancer control continuum: Review of technology, environment, and theory.

Taber JM, Dickerman BA, Okhovat JP, Geller AC, Dwyer LA, Hartman AM, Perna FM.

Prev Med. 2018 Jun;111:451-458. doi: 10.1016/j.ypmed.2017.12.019. Epub 2017 Dec 23. Review.

13.

Medical Care Avoidance Among Older Adults.

Leyva B, Taber JM, Trivedi AN.

J Appl Gerontol. 2020 Jan;39(1):74-85. doi: 10.1177/0733464817747415. Epub 2017 Dec 18.

PMID:
29249189
14.

Self-Regulation Principles Underlying Risk Perception and Decision Making within the Context of Genomic Testing.

Cameron LD, Biesecker BB, Peters E, Taber JM, Klein WMP.

Soc Personal Psychol Compass. 2017 May;11(5). pii: e12315. doi: 10.1111/spc3.12315. Epub 2017 May 5.

15.

Interdisciplinary Perspectives on Sun Safety.

Geller AC, Jablonski NG, Pagoto SL, Hay JL, Hillhouse J, Buller DB, Kenney WL, Robinson JK, Weller RB, Moreno MA, Gilchrest BA, Sinclair C, Arndt J, Taber JM, Morris KL, Dwyer LA, Perna FM, Klein WMP, Suls J.

JAMA Dermatol. 2018 Jan 1;154(1):88-92. doi: 10.1001/jamadermatol.2017.4201. Review.

16.

Interest in and reactions to genetic risk information: The role of implicit theories and self-affirmation.

Taber JM, Klein WMP, Persky S, Ferrer RA, Kaufman AR, Thai CL, Harris PR.

Soc Sci Med. 2017 Oct;190:101-110. doi: 10.1016/j.socscimed.2017.08.010. Epub 2017 Aug 14.

PMID:
28858695
17.

Reactions to clinical reinterpretation of a gene variant by participants in a sequencing study.

Taber JM, Klein WMP, Lewis KL, Johnston JJ, Biesecker LG, Biesecker BB.

Genet Med. 2018 Mar;20(3):337-345. doi: 10.1038/gim.2017.88. Epub 2017 Jul 27.

18.

Heart disease versus cancer: understanding perceptions of population prevalence and personal risk.

Scheideler JK, Taber JM, Ferrer RA, Grenen EG, Klein WMP.

J Behav Med. 2017 Oct;40(5):839-845. doi: 10.1007/s10865-017-9860-0. Epub 2017 Jun 2.

PMID:
28577198
19.

Rethinking physical activity communication: using focus groups to understand women's goals, values, and beliefs to improve public health.

Segar M, Taber JM, Patrick H, Thai CL, Oh A.

BMC Public Health. 2017 May 18;17(1):462. doi: 10.1186/s12889-017-4361-1.

20.

Research on Skin Cancer-Related Behaviors and Outcomes in the NIH Grant Portfolio, 2000-2014: Skin Cancer Intervention Across the Cancer Control Continuum (SCI-3C).

Perna FM, Dwyer LA, Tesauro G, Taber JM, Norton WE, Hartman AM, Geller AC.

JAMA Dermatol. 2017 May 1;153(5):398-405. doi: 10.1001/jamadermatol.2016.6216.

21.

Engagement with Genetic Information and Uptake of Genetic Testing: the Role of Trust and Personal Cancer History.

Roberts MC, Taber JM, Klein WM.

J Cancer Educ. 2018 Aug;33(4):893-900. doi: 10.1007/s13187-016-1160-9.

PMID:
28105554
22.

Lay Awareness of the Relationship between Age and Cancer Risk.

Taber JM, Klein WM, Suls JM, Ferrer RA.

Ann Behav Med. 2017 Apr;51(2):214-225. doi: 10.1007/s12160-016-9845-1.

PMID:
27752991
23.

Integrating knowledge across domains to advance the science of health behavior: overcoming challenges and facilitating success.

Klein WM, Grenen EG, O'Connell M, Blanch-Hartigan D, Chou WS, Hall KL, Taber JM, Vogel AL.

Transl Behav Med. 2017 Mar;7(1):98-105. doi: 10.1007/s13142-016-0433-5.

24.

A Pilot Test of Self-Affirmations to Promote Smoking Cessation in a National Smoking Cessation Text Messaging Program.

Taber JM, Klein WM, Ferrer RA, Augustson E, Patrick H.

JMIR Mhealth Uhealth. 2016 Jun 8;4(2):e71. doi: 10.2196/mhealth.5635.

25.

Spontaneous self-affirmation is associated with psychological well-being: Evidence from a US national adult survey sample.

Emanuel AS, Howell JL, Taber JM, Ferrer RA, Klein WM, Harris PR.

J Health Psychol. 2018 Jan;23(1):95-102. doi: 10.1177/1359105316643595. Epub 2016 May 9.

PMID:
27160152
26.

The role of conviction in personal disease risk perceptions: What can we learn from research on attitude strength?

Taber JM, Klein WM.

Soc Personal Psychol Compass. 2016 Apr;10(4):202-218. Epub 2016 Apr 3.

27.

Optimism and Spontaneous Self-affirmation are Associated with Lower Likelihood of Cognitive Impairment and Greater Positive Affect among Cancer Survivors.

Taber JM, Klein WM, Ferrer RA, Kent EE, Harris PR.

Ann Behav Med. 2016 Apr;50(2):198-209. doi: 10.1007/s12160-015-9745-9.

28.

Associations of spontaneous self-affirmation with health care experiences and health information seeking in a national survey of US adults.

Taber JM, Howell JL, Emanuel AS, Klein WM, Ferrer RA, Harris PR.

Psychol Health. 2016;31(3):292-309. doi: 10.1080/08870446.2015.1085986. Epub 2015 Sep 28.

29.

Smoke-free air laws and quit attempts: Evidence for a moderating role of spontaneous self-affirmation.

Persoskie A, Ferrer RA, Taber JM, Klein WM, Parascandola M, Harris PR.

Soc Sci Med. 2015 Sep;141:46-55. doi: 10.1016/j.socscimed.2015.07.015. Epub 2015 Jul 20.

PMID:
26246033
30.

Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.

Taber JM, Aspinwall LG, Stump TK, Kohlmann W, Champine M, Leachman SA.

J Behav Med. 2015 Oct;38(5):740-53. doi: 10.1007/s10865-015-9648-z. Epub 2015 Jul 16.

31.

Perceived ambiguity as a barrier to intentions to learn genome sequencing results.

Taber JM, Klein WM, Ferrer RA, Han PK, Lewis KL, Biesecker LG, Biesecker BB.

J Behav Med. 2015 Oct;38(5):715-26. doi: 10.1007/s10865-015-9642-5. Epub 2015 May 24.

32.

Effectiveness of internet-based affect induction procedures: A systematic review and meta-analysis.

Ferrer RA, Grenen EG, Taber JM.

Emotion. 2015 Dec;15(6):752-62. doi: 10.1037/emo0000035. Epub 2015 May 4. Review.

PMID:
25938613
33.

Impact of melanoma genetic test reporting on perceived control over melanoma prevention.

Aspinwall LG, Stump TK, Taber JM, Kohlmann W, Leaf SL, Leachman SA.

J Behav Med. 2015 Oct;38(5):754-65. doi: 10.1007/s10865-015-9631-8. Epub 2015 Mar 31.

34.

Information Avoidance Tendencies, Threat Management Resources, and Interest in Genetic Sequencing Feedback.

Taber JM, Klein WM, Ferrer RA, Lewis KL, Harris PR, Shepperd JA, Biesecker LG.

Ann Behav Med. 2015 Aug;49(4):616-21. doi: 10.1007/s12160-014-9679-7.

35.

Framing recommendations to promote prevention behaviors among people at high risk: A simulation study of responses to melanoma genetic test reporting.

Taber JM, Aspinwall LG.

J Genet Couns. 2015 Oct;24(5):771-82. doi: 10.1007/s10897-014-9808-2. Epub 2015 Jan 14.

PMID:
25582532
36.

The role of current affect, anticipated affect and spontaneous self-affirmation in decisions to receive self-threatening genetic risk information.

Ferrer RA, Taber JM, Klein WM, Harris PR, Lewis KL, Biesecker LG.

Cogn Emot. 2015;29(8):1456-65. doi: 10.1080/02699931.2014.985188. Epub 2014 Dec 8.

37.

Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.

Taber JM, Chang CQ, Lam TK, Gillanders EM, Hamilton JG, Schully SD.

Public Health Genomics. 2015;18(2):67-77. doi: 10.1159/000368745.

38.

Why do people avoid medical care? A qualitative study using national data.

Taber JM, Leyva B, Persoskie A.

J Gen Intern Med. 2015 Mar;30(3):290-7. doi: 10.1007/s11606-014-3089-1. Epub 2014 Nov 12.

39.

Dispositional optimism and perceived risk interact to predict intentions to learn genome sequencing results.

Taber JM, Klein WM, Ferrer RA, Lewis KL, Biesecker LG, Biesecker BB.

Health Psychol. 2015 Jul;34(7):718-28. doi: 10.1037/hea0000159. Epub 2014 Oct 13.

40.

Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.

Aspinwall LG, Taber JM, Kohlmann W, Leaf SL, Leachman SA.

Genet Med. 2014 Nov;16(11):846-53. doi: 10.1038/gim.2014.37. Epub 2014 Apr 24.

41.

Preferences for blood-based colon cancer screening differ by race/ethnicity.

Taber JM, Aspinwall LG, Heichman KA, Kinney AY.

Am J Health Behav. 2014 May;38(3):351-61. doi: 10.5993/AJHB.38.3.4.

PMID:
24636031
42.

Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.

Aspinwall LG, Taber JM, Kohlmann W, Leaf SL, Leachman SA.

J Genet Couns. 2014 Jun;23(3):421-37. doi: 10.1007/s10897-013-9676-1. Epub 2013 Dec 10.

43.

Partner involvement in conduct of skin self-examinations remains low following CDKN2A/p16 genetic test reporting and counseling.

Taber JM, Aspinwall LG, Leaf SL, Kohlmann W, Leachman SA.

J Am Acad Dermatol. 2013 Nov;69(5):842-844. doi: 10.1016/j.jaad.2013.06.048. No abstract available.

PMID:
24124830
44.

Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.

Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1687-97. doi: 10.1158/1055-9965.EPI-13-0422. Epub 2013 Aug 15.

45.

Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.

Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA.

Psychooncology. 2013 Feb;22(2):276-89. doi: 10.1002/pon.2080. Epub 2011 Oct 7.

PMID:
23382133
46.

Parental preferences for CDKN2A/p16 testing of minors.

Taber JM, Aspinwall LG, Kohlmann W, Dow R, Leachman SA.

Genet Med. 2010 Dec;12(12):823-38. doi: 10.1097/GIM.0b013e3181f87278.

PMID:
21045708

Supplemental Content

Loading ...
Support Center